Ping Liu

5PUBLICATIONS
11CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMicroelectromechanical systems (MEMS)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2026
Guanxinkang Decoction and Its Key Component Isotanshinone II Ameliorate Atherosclerosis Through Modulation of STAT3/ CD36 Signaling and Macrophage Efferocytosis: An Integrated Network Pharmacology and Experimental Validation Study.

|Dec 30, 2025
Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosis.

Zhenyue Fu, Shuo Yang, Xindi Chang

|May 01, 2024
The role of IFI16 in regulating PANoptosis and implication in heart diseases.

Xindi Chang, Bei Wang, Yingli Zhao

|Sep 05, 2022
Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease.

Xiaoteng Feng, Yifan Zhang, Min Du

|May 02, 2022
The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.

SiJin Li, Ping Liu, XiaoTeng Feng

Pageof 1

Frequent Collaborators

2 joint publications

Yiru Wang

1 joint publications

XiaoTeng Feng

1 joint publications

Shuaijie Guo

1 joint publications

Chen Gao